-
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Consensus Recommendation of "Moderate Buy" by Analysts
ソース: Buzz FX / 13 1 2025 03:31:15 America/Chicago
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Consensus Recommendation of "Moderate Buy" by Analysts Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Rhythm Pharmaceuticals, Inc.
Read more...